Gene Express' David Lester, Ph.D. to Participate in Keynote Panel Discussion at the Pharmaceutical Marketing Research Group's 2008 Annual National Con
Gene Express, Inc. today announced that David S. Lester, Ph.D., Senior Vice President of Strategy and Corporate Development, will be one of three panel members discussing the dramatic changes the pharmaceutical industry is undergoing, at the Pharmaceutical Marketing Research Group's 2008 Annual National Conference in Phoenix, AZ, March 9-11.
Dr. Lester will be participating in the panel discussion entitled "Crystal Ball Gazing: The Pharmaceutical Industry in Transition -- Pharma 2020," immediately following the keynote speaker: Ken Fisher, CEO of Fisher Investments, Forbes magazine columnist and author of "The Only Three Questions That Count: Investing by Knowing What Other's Don't," on Monday, March 10. Dr. Lester's talk will focus on the impact of personalized medicine on the pharmaceutical industry, and how this relationship is changing.
David S. Lester received his Ph.D. in Biological Sciences from Northwestern University and has held positions at Harvard University Medical School, the Weizmann Institute of Science (Israel) and National Institute of Neurological Disorders and Stroke at the National Institute of Health. He is currently serving as Senior Vice President at Gene Express, Inc. in charge of Strategy and Corporate Development. Dr. Lester is also President of Innovative Technologies for Health and Wellness (ITHW, Inc.). He has held executive positions, and played pivotal roles at Pfizer, in the Global Clinical Technology and Human Health Technologies Groups, as well as at Pharmacia Corp., and at the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Dr. Lester's Research interests have included the incorporation of innovative technologies into clinical trials for the use of biomarkers or surrogate endpoints. He has an extensive publication record including five edited volumes. Dr. Lester is active in numerous professional societies and has a strong record in public science policy activities.
Source : http://www.marketwire.com/mw/release.do?id=828374
Dr. Lester will be participating in the panel discussion entitled "Crystal Ball Gazing: The Pharmaceutical Industry in Transition -- Pharma 2020," immediately following the keynote speaker: Ken Fisher, CEO of Fisher Investments, Forbes magazine columnist and author of "The Only Three Questions That Count: Investing by Knowing What Other's Don't," on Monday, March 10. Dr. Lester's talk will focus on the impact of personalized medicine on the pharmaceutical industry, and how this relationship is changing.
David S. Lester received his Ph.D. in Biological Sciences from Northwestern University and has held positions at Harvard University Medical School, the Weizmann Institute of Science (Israel) and National Institute of Neurological Disorders and Stroke at the National Institute of Health. He is currently serving as Senior Vice President at Gene Express, Inc. in charge of Strategy and Corporate Development. Dr. Lester is also President of Innovative Technologies for Health and Wellness (ITHW, Inc.). He has held executive positions, and played pivotal roles at Pfizer, in the Global Clinical Technology and Human Health Technologies Groups, as well as at Pharmacia Corp., and at the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Dr. Lester's Research interests have included the incorporation of innovative technologies into clinical trials for the use of biomarkers or surrogate endpoints. He has an extensive publication record including five edited volumes. Dr. Lester is active in numerous professional societies and has a strong record in public science policy activities.
Source : http://www.marketwire.com/mw/release.do?id=828374
Posts
Post a Comment